マーケットレポート詳細
眼内レンズの世界市場：2029年に至るタイプ別、主要国地域別予測
Intraocular Lens Market byType (Monofocal, Premium, Phakic), Material (Hydrophobic, Hydrophilic, Silicone) Application (Cataract, Presbyopia, Corneal Disorder), End User, Unmet Need, Buying Criteria, Reimbursement - Global Forecast to 2029
- 出版元：MarketsandMarkets
出版元について - 発行年：2023年12月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文 240ページになります。
- 商品コード：MAM3496
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
眼内レンズの世界市場規模は2023年で42億ドル、2029年に60億ドル、市場の平均年成長率は6.3%にて増加が見込まれています。
レポートは眼内レンズの世界市場について2029年までの市場予測データ(金額US$、数量Units)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（マテリアル別市場、用途別市場、等）を中心に構成されています。また競合状況、主要企業情報（15社）、サプライチェーン分析、技術分析なども加味し、眼内レンズ市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆眼内レンズの世界市場予測2021-2029年
・市場規模(US$)
・数量（Units）
◆マテリアル別、市場-2029年
・疎水性アクリル眼内レンズ
・親水性アクリル眼内レンズ
・ポリメチルメタクリレート
・シリコーン眼内レンズ
・その他マテリアル
※(市場規模US$)
◆用途別、市場-2029年
・白内障手術
・老眼
・角膜障害
・その他用途
※(市場規模US$)
◆タイプ別、市場-2029年
単焦点眼内レンズ
・非球面単焦点眼内レンズ
・球面単焦点眼内レンズ
プレミアム眼内レンズ
・多焦点眼内レンズ
・焦点深度拡張型眼内レンズ（EDOF）
・調節眼内レンズ
有水晶体眼内レンズ
その他眼内レンズ
※(市場規模US$、数量Units)
◆エンドユーザー別、市場-2029年
・病院
・眼科
・眼科研究機関
・その他エンドユーザー
※(市場規模US$)
◆主要国地域別市場-2029年
北米
・米国、カナダ
欧州
・ドイツ、フランス、英国
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア、韓国
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
※地域、国別に全セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス
・貿易分析
・関税と規制状況
・エコシステム、マップ
・バリューチェーン分析
・サプライチェーン分析
・技術分析
・ファイブフォース分析
・特許分析
・平均価格分析
・競合状況
・市場シェア分析
◆ 眼内レンズの主要企業プロフィール動向
・ALCON, INC
・JOHNSON & JOHNSON VISION CARE, INC
・BAUSCH + LOMB
・CARL ZEISS MEDITEC AG
・HOYA SURGICAL OPTICS
・STAAR SURGICAL COMPANY
・SANTEN PHARMACEUTICAL CO, LTD
・株式会社ニデック
・RAYNER GROUP
・BVI
・OPHTEC BV
・SAV-IOL SA
・APPASAMY ASSOCIATES PRIVATE LIMITED
・ATIA VISION, INC
その他企業
・BIOTECH
・TELEON SURGICAL BV
・OMNI LENS PVT LTD
・EYEKON MEDICAL
・HUMANOPTICS HOLDING AG
・CARE GROUP
・SIFI SPA
・HANITA LENSES LTD
・EXCELLENT HI-CARE PVT LTD
・ADVIN HEALTH CARE
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 TYPE DEFINITION 32
1.2.2 MATERIAL DEFINITION
1.2.3 APPLICATION DEFINITION
1.2.4 END-USER DEFINITION
1.2.5 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SEGMENTATION
1.3.1 MARKETS COVERED 35
・ FIGURE 1 INTRAOCULAR LENS MARKET
1.3.2 YEARS CONSIDERED 36
1.4 CURRENCY CONSIDERED
・ TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY DATA
・ FIGURE 3 PRIMARY SOURCES
2.1.2.1 KEY DATA FROM PRIMARY SOURCES
2.1.2.2 KEY INDUSTRY INSIGHTS
・ FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY/DEMAND-SIDE PARTICIPANTS
・ FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION
・ FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
・ FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: ALCON, INC.
・ FIGURE 8 SUPPLY-SIDE ANALYSIS OF TOP COMPANIES (2022)
・ FIGURE 9 DEMAND-SIDE MARKET ESTIMATION FOR INTRAOCULAR LENSES
・ FIGURE 10 INTRAOCULAR LENS MARKET: CAGR PROJECTIONS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2029)
・ FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
3 EXECUTIVE SUMMARY
・ FIGURE 12 INTRAOCULAR LENS MARKET, BY TYPE, 2023 VS. 2029 (USD MILLION)
・ FIGURE 13 INTRAOCULAR LENS MARKET, BY MATERIAL, 2023 VS. 2029 (USD MILLION)
・ FIGURE 14 INTRAOCULAR LENS MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
・ FIGURE 15 INTRAOCULAR LENS MARKET, BY END USER, 2023 VS. 2029 (USD MILLION)
・ FIGURE 16 GEOGRAPHIC SNAPSHOT OF INTRAOCULAR LENS MARKET
4 PREMIUM INSIGHTS
4.1 INTRAOCULAR LENS MARKET OVERVIEW
・ FIGURE 17 RISING INCIDENCE OF CHRONIC DISEASES AND SUBSEQUENT RISE IN CATARACT SURGERIES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY END USER
・ FIGURE 18 HOSPITALS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 INTRAOCULAR LENS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 19 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.4 INTRAOCULAR LENS MARKET: REGIONAL MIX
・ FIGURE 20 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.5 INTRAOCULAR LENS MARKET: DEVELOPED COUNTRIES VS. EMERGING ECONOMIES
・ FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 22 INTRAOCULAR LENS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 INCREASING GERIATRIC POPULATION AND SUBSEQUENT RISE IN OPHTHALMIC DISORDERS
・ FIGURE 23 COMPARATIVE ANALYSIS OF POPULATION AGED 65 & ABOVE
・ FIGURE 24 REGIONS WITH PEOPLE AGED 65 & ABOVE (50 MILLION & ABOVE)
5.2.1.2 RISING NUMBER OF CATARACT SURGERIES
・ FIGURE 25 GLOBAL DISTANCE VISION IMPAIRMENT STATISTICS (2023)
5.2.1.3 GROWING TECHNOLOGICAL ADVANCEMENTS IN IOLS
5.2.2 RESTRAINS
5.2.2.1 RISING COST OF INTRAOCULAR LENSES
5.2.3 OPPORTUNITIES
5.2.3.1 HIGH GROWTH POTENTIAL OF EMERGING ECONOMIES
5.2.4 CHALLENGES
5.2.4.1 SHORTAGE OF SKILLED OPHTHALMOLOGISTS
5.3 TRADE ANALYSIS
・ TABLE 2 TOP EXPORTERS OF LENSES (APART FROM CAMERAS, PROJECTORS, OR PHOTOGRAPHIC ENLARGERS/REDUCERS), 2022
5.4 TARIFF AND REGULATORY LANDSCAPE
5.4.1 TARIFF FOR INTRAOCULAR LENSES
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.4.3 NORTH AMERICA
5.4.4 EUROPE
5.4.5 ASIA PACIFIC
・ TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 6 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.5 ECOSYSTEM MARKET/MAP
・ FIGURE 26 ECOSYSTEM MARKET/MAP
5.6 VALUE CHAIN ANALYSIS
・ FIGURE 27 INTRAOCULAR LENS MARKET: VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
・ FIGURE 28 INTRAOCULAR LENS MARKET: SUPPLY CHAIN ANALYSIS
5.8 TECHNOLOGY ANALYSIS
5.8.1 TECHNOLOGICAL ADVANCEMENTS IN MATERIALS, DESIGNS, AND MANUFACTURING TECHNIQUES
5.8.2 AI INTEGRATION IN INTRAOCULAR LENSES
5.9 PORTER’S FIVE FORCE ANALYSIS
・ TABLE 7 INTRAOCULAR LENS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 BARGAINING POWER OF BUYERS
5.9.2 BARGAINING POWER OF SUPPLIERS
5.9.3 THREAT OF NEW ENTRANTS
5.9.4 THREAT OF SUBSTITUTES
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 PATENT ANALYSIS
5.10.1 PATENT PUBLICATION TRENDS FOR INTRAOCULAR LENS MARKET
・ FIGURE 29 PATENT PUBLICATION TRENDS (JANUARY 2011–NOVEMBER 2023)
・ FIGURE 30 TOP APPLICANTS (COMPANIES/INSTITUTES) FOR INTRAOCULAR LENS PATENTS (JANUARY 2011–NOVEMBER 2023)
・ FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR INTRAOCULAR LENS PATENTS (JANUARY 2011– NOVEMBER 2023)
5.11 TRADE ANALYSIS
・ TABLE 8 INTRAOCULAR LENS EXPORT DATA, BY COUNTRY (2023)
・ TABLE 9 INTRAOCULAR LENS IMPORT DATA, BY COUNTRY (2022)
5.12 KEY CONFERENCES & EVENTS
・ TABLE 10 INTRAOCULAR LENS MARKET: DETAILED LIST OF CONFERENCES & EVENTS (2023−2024)
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
・ FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
・ TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
5.13.2 BUYING CRITERIA
・ FIGURE 33 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
・ TABLE 12 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
5.14 PRICING ANALYSIS
・ TABLE 13 PRICING ANALYSIS OF INTRAOCULAR LENSES
5.14.1 AVERAGE SELLING PRICE TREND, BY REGION
・ TABLE 14 AVERAGE SELLING PRICE TREND, BY REGION (2022)
5.15 REIMBURSEMENT SCENARIO IN INTRAOCULAR LENS MARKET
5.16 UNMET NEEDS IN INTRAOCULAR LENS MARKET
・ TABLE 15 UNMET NEEDS IN INTRAOCULAR LENS MARKET
5.16.1 END-USER EXPECTATIONS IN INTRAOCULAR LENS MARKET
・ TABLE 16 END-USER EXPECTATIONS IN INTRAOCULAR LENS MARKET
6 INTRAOCULAR LENS MARKET, BY MATERIAL
6.1 INTRODUCTION
・ TABLE 17 INTRAOCULAR LENS MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
6.2 HYDROPHOBIC ACRYLIC IOL
6.2.1 INCREASED BIOCOMPATIBILITY AND HEIGHTENED STABILITY TO DRIVE MARKET
・ TABLE 18 INTRAOCULAR LENS MARKET FOR HYDROPHOBIC ACRYLIC IOL, BY COUNTRY, 2021–2029 (USD MILLION)
6.3 HYDROPHILIC ACRYLIC IOL
6.3.1 GLARE REDUCTION AND INCREASED COMPRESSIBILITY TO PROPEL MARKET
・ TABLE 19 INTRAOCULAR LENS MARKET FOR HYDROPHILIC ACRYLIC IOL, BY COUNTRY, 2021–2029 (USD MILLION)
6.4 POLYMETHYLMETHACRYLATE
6.4.1 LOW MATERIAL COST AND ADVANCED DURABILITY TO BOOST DEMAND
・ TABLE 20 INTRAOCULAR LENS MARKET FOR POLYMETHYLMETHACRYLATE, BY COUNTRY, 2021–2029 (USD MILLION)
6.5 SILICONE IOL
6.5.1 LOW AWARENESS AND LIMITED FOLDABILITY TO RESTRAIN MARKET
・ TABLE 21 INTRAOCULAR LENS MARKET FOR SILICONE IOL, BY COUNTRY, 2021–2029 (USD MILLION)
6.6 OTHER MATERIALS
・ TABLE 22 INTRAOCULAR LENS MARKET FOR OTHER MATERIALS, BY COUNTRY, 2021–2029 (USD MILLION)
7 INTRAOCULAR LENS MARKET, BY APPLICATION
7.1 INTRODUCTION
・ TABLE 23 INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
7.2 CATARACT SURGERIES
7.2.1 RISING GROWTH IN GERIATRIC POPULATION TO DRIVE MARKET
・ TABLE 24 INTRAOCULAR LENS MARKET FOR CATARACT SURGERIES, BY COUNTRY, 2021–2029 (USD MILLION)
7.3 PRESBYOPIA 95
7.3.1 GROWING AWARENESS OF TECHNOLOGICALLY ADVANCED IOLS TO SUPPORT MARKET GROWTH
・ TABLE 25 INTRAOCULAR LENS MARKET FOR PRESBYOPIA, BY COUNTRY, 2021–2029 (USD MILLION)
7.4 CORNEAL DISORDERS
7.4.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES TO BOOST DEMAND
・ TABLE 26 INTRAOCULAR LENS MARKET FOR CORNEAL DISORDERS, BY COUNTRY, 2021–2029 (USD MILLION)
7.5 OTHER APPLICATIONS
・ TABLE 27 INTRAOCULAR LENS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
8 INTRAOCULAR LENS MARKET, BY MATERIAL
8.1 INTRODUCTION
・ TABLE 28 INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
8.2 MONOFOCAL IOL
・ TABLE 29 INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 30 INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 31 INTRAOCULAR LENS MARKET VOLUME FOR MONOFOCAL IOL, BY COUNTRY, 2021–2029 (UNITS)
8.2.1 ASPHERIC MONOFOCAL IOL
8.2.1.1 INCREASED VISUAL QUALITY AND PERFORMANCE TO PROPEL MARKET
・ TABLE 32 INTRAOCULAR LENS MARKET FOR ASPHERIC MONOFOCAL IOL, BY COUNTRY, 2021–2029 (USD MILLION)
8.2.2 SPHERIC MONOFOCAL IOL
8.2.2.1 COST-EFFECTIVENESS TO DRIVE MARKET
・ TABLE 33 INTRAOCULAR LENS MARKET FOR SPHERIC MONOFOCAL IOL, BY COUNTRY, 2021–2029 (USD MILLION)
8.3 PREMIUM IOL 106
・ TABLE 34 INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 35 INTRAOCULAR LENS MARKET VOLUME FOR PREMIUM IOL, BY COUNTRY, 2021–2029 (UNITS)
8.3.1 MULTIFOCAL IOL
8.3.1.1 ENHANCED VISUAL ACUITY TO SUPPORT MARKET GROWTH
・ TABLE 36 INTRAOCULAR LENS MARKET FOR MULTIFOCAL IOL, BY COUNTRY, 2021–2029 (USD MILLION)
8.3.2 EXTENDED DEPTH OF FOCUS (EDOF) IOL
8.3.2.1 BROADER RANGE OF CLEAR VISION COMPARED TO MONOFOCAL IOL TO DRIVE MARKET
・ TABLE 37 INTRAOCULAR LENS MARKET FOR EDOF IOL, BY COUNTRY, 2021–2029 (USD MILLION)
8.3.3 ACCOMMODATING IOL 111
8.3.3.1 HIGH UTILIZATION IN CATARACT CORRECTION TO DRIVE MARKET
・ TABLE 38 INTRAOCULAR LENS MARKET FOR ACCOMMODATING IOL, BY COUNTRY, 2021–2029 (USD MILLION)
8.4 PHAKIC IOL 112
8.4.1 LIMITED AWARENESS AND COST CONCERNS TO RESTRAIN MARKET
・ TABLE 39 INTRAOCULAR LENS MARKET FOR PHAKIC IOL, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 40 INTRAOCULAR LENS MARKET VOLUME FOR PHAKIC IOL, BY COUNTRY, 2021–2029 (UNITS)
8.5 OTHER IOLS 114
・ TABLE 41 INTRAOCULAR LENS MARKET FOR OTHER IOLS, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 42 INTRAOCULAR LENS MARKET VOLUME FOR OTHER IOLS, BY COUNTRY, 2021–2029 (UNITS)
9 INTRAOCULAR LENS MARKET, BY END USER
9.1 INTRODUCTION
・ TABLE 43 INTRAOCULAR LENS MARKET BY END USER, 2021–2029 (USD MILLION)
9.2 HOSPITALS 117
9.2.1 HIGH PURCHASING POWER FOR ADVANCED EQUIPMENT TO PROPEL MARKET
・ TABLE 44 INTRAOCULAR LENS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2029 (USD MILLION)
9.3 OPHTHALMOLOGY CLINICS
9.3.1 REDUCED WAITING TIME & MINIMAL COST OF DIAGNOSTIC & SURGICAL PROCEDURES TO PROPEL MARKET 118
・ TABLE 45 INTRAOCULAR LENS MARKET FOR CLINICS, BY COUNTRY, 2021–2029 (USD MILLION)
9.4 EYE RESEARCH INSTITUTES
9.4.1 INCREASING R&D ON IOL TECHNOLOGIES TO DRIVE MARKET
・ TABLE 46 INTRAOCULAR LENS MARKET FOR EYE RESEARCH INSTITUTES, BY COUNTRY, 2021–2029 (USD MILLION)
9.5 OTHER END USERS
・ TABLE 47 INTRAOCULAR LENS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2029 (USD MILLION)
10 INTRAOCULAR LENS MARKET, BY REGION
10.1 INTRODUCTION
・ FIGURE 34 INTRAOCULAR LENS MARKET REGIONAL SNAPSHOT
・ TABLE 48 INTRAOCULAR LENS MARKET, BY REGION, 2021–2029 (USD MILLION)
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA: RECESSION IMPACT
・ FIGURE 35 NORTH AMERICA: INTRAOCULAR LENS MARKET SNAPSHOT
・ TABLE 49 NORTH AMERICA: INTRAOCULAR LENS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 50 NORTH AMERICA: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 51 NORTH AMERICA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 52 NORTH AMERICA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 53 NORTH AMERICA: INTRAOCULAR LENS MARKET MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 54 NORTH AMERICA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 55 NORTH AMERICA: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.2.2 US
10.2.2.1 FAVORABLE REIMBURSEMENT POLICIES TO DRIVE MARKET
・ TABLE 56 US: KEY MACROINDICATORS
・ TABLE 57 US: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 58 US: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 59 US: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 60 US: INTRAOCULAR LENS MARKET MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 61 US: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 62 US: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.2.3 CANADA
10.2.3.1 LARGE TARGET POPULATION TO DRIVE MARKET
・ TABLE 63 CANADA: KEY MACROINDICATORS 131
・ TABLE 64 CANADA: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 65 CANADA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 66 CANADA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 67 CANADA: INTRAOCULAR LENS MARKET MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 68 CANADA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 69 CANADA: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.3 EUROPE
10.3.1 EUROPE: RECESSION IMPACT
・ TABLE 70 EUROPE: INTRAOCULAR LENS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 71 EUROPE: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 72 EUROPE: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 73 EUROPE: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 74 EUROPE: INTRAOCULAR LENS MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 75 EUROPE: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 76 EUROPE: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.3.2 GERMANY
10.3.2.1 INCREASING PUBLIC HEALTHCARE EXPENDITURE TO DRIVE MARKET
・ TABLE 77 GERMANY: KEY MACROINDICATORS 137
・ TABLE 78 GERMANY: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 79 GERMANY: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 80 GERMANY: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 81 GERMANY: INTRAOCULAR LENS MARKET MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 82 GERMANY: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 83 GERMANY: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 GOVERNMENT INITIATIVES FOR VISUAL CARE AWARENESS TO SUPPORT MARKET GROWTH
・ TABLE 84 FRANCE: KEY MACROINDICATORS 140
・ TABLE 85 FRANCE: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 86 FRANCE: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 87 FRANCE: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 88 FRANCE: INTRAOCULAR LENS MARKET MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 89 FRANCE: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 90 FRANCE: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.3.4 UK
10.3.4.1 GROWING HEALTHCARE EXPENDITURE TO DRIVE MARKET
・ TABLE 91 UK: KEY MACROINDICATORS
・ TABLE 92 UK: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 93 UK: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 94 UK: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 95 UK: INTRAOCULAR LENS MARKET MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 96 UK: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 97 UK: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.3.5 ITALY
10.3.5.1 FAVORABLE R&D INITIATIVES FOR EYE CARE TO SUPPORT MARKET GROWTH
・ TABLE 98 ITALY: KEY MACROINDICATORS 146
・ TABLE 99 ITALY: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 100 ITALY: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 101 ITALY: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 102 ITALY: INTRAOCULAR LENS MARKET MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 103 ITALY: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 104 ITALY: INTRAOCULAR LENS MARKET, BY END-USER, 2021–2029 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 INCREASING HEALTHCARE SPENDING TO DRIVE MARKET GROWTH IN SPAIN
・ TABLE 105 SPAIN: KEY MACROINDICATORS 148
・ TABLE 106 SPAIN: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 107 SPAIN: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 108 SPAIN: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 109 SPAIN: INTRAOCULAR LENS MARKET MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 110 SPAIN: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 111 SPAIN: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.3.7 REST OF EUROPE
・ TABLE 112 REST OF EUROPE: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 113 REST OF EUROPE: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 114 REST OF EUROPE: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 115 REST OF EUROPE: INTRAOCULAR LENS MARKET MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 116 REST OF EUROPE: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 117 REST OF EUROPE: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC: RECESSION IMPACT
・ FIGURE 36 ASIA PACIFIC: INTRAOCULAR LENS MARKET SNAPSHOT
・ TABLE 118 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 119 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 120 ASIA PACIFIC: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 121 ASIA PACIFIC: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 122 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 123 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 124 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 RISING GERIATRIC POPULATION TO BOOST DEMAND
・ TABLE 125 JAPAN: KEY MACROINDICATORS 157
・ TABLE 126 JAPAN: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 127 JAPAN: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 128 JAPAN: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 129 JAPAN: INTRAOCULAR LENS MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 130 JAPAN: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 131 JAPAN: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.4.3 CHINA
10.4.3.1 IMPROVED HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
・ TABLE 132 CHINA: KEY MACROINDICATORS 160
・ TABLE 133 CHINA: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 134 CHINA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 135 CHINA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 136 CHINA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 137 CHINA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 138 CHINA: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.4.4 INDIA
10.4.4.1 RISING NUMBER OF CATARACT SURGERIES TO DRIVE MARKET
・ TABLE 139 INDIA: KEY MACROINDICATORS 163
・ TABLE 140 INDIA: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 141 INDIA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 142 INDIA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 143 INDIA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 144 INDIA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 145 INDIA: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.4.5 AUSTRALIA
10.4.5.1 HIGH FOCUS ON R&D FOR ADVANCED IOLS TO DRIVE MARKET
・ TABLE 146 AUSTRALIA: KEY MACROINDICATORS
・ TABLE 147 AUSTRALIA: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 148 AUSTRALIA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 149 AUSTRALIA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 150 AUSTRALIA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 151 AUSTRALIA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 152 AUSTRALIA: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.4.6 SOUTH KOREA
10.4.6.1 RISING ADOPTION OF TECHNOLOGICALLY ADVANCED IOLS TO BOOST DEMAND
・ TABLE 153 SOUTH KOREA: KEY MACROINDICATORS
・ TABLE 154 SOUTH KOREA: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 155 SOUTH KOREA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 156 SOUTH KOREA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 157 SOUTH KOREA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 158 SOUTH KOREA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 159 SOUTH KOREA: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.4.7 REST OF ASIA PACIFIC
・ TABLE 160 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 161 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 162 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 163 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 164 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 165 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 LATIN AMERICA: RECESSION IMPACT
・ TABLE 166 LATIN AMERICA: INTRAOCULAR LENS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 167 LATIN AMERICA: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 168 LATIN AMERICA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 169 LATIN AMERICA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 170 LATIN AMERICA: INTRAOCULAR LENS MARKET MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 171 LATIN AMERICA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 172 LATIN AMERICA: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.5.2 BRAZIL
10.5.2.1 GOVERNMENT INITIATIVES FOR HEALTHCARE INFRASTRUCTURE TO BOOST MARKET
・ TABLE 173 BRAZIL: KEY MACROINDICATORS 176
・ TABLE 174 BRAZIL: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 175 BRAZIL: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 176 BRAZIL: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 177 BRAZIL: INTRAOCULAR LENS MARKET MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 178 BRAZIL: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 179 BRAZIL: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.5.3 MEXICO
10.5.3.1 RISING INCIDENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH 179
・ TABLE 180 MEXICO: KEY MACROINDICATORS 179
・ TABLE 181 MEXICO: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 182 MEXICO: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 183 MEXICO: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 184 MEXICO: INTRAOCULAR LENS MARKET MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 185 MEXICO: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 186 MEXICO: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.5.4 REST OF LATIN AMERICA
・ TABLE 187 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 188 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 189 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 190 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 191 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 192 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.5.5 MIDDLE EAST & AFRICA
10.5.5.1 GOVERNMENT-FUNDED INITIATIVES FOR CATARACT TREATMENT TO DRIVE MARKET
10.5.5.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
・ TABLE 193 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 194 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 195 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 196 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET MARKET, BY MATERIAL, 2021–2029 (USD MILLION)
・ TABLE 197 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 198 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET, BY END USER, 2021–2029 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY STRATEGIES/RIGHT TO WIN
・ FIGURE 37 STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS
・ FIGURE 38 REVENUE SHARE ANALYSIS (2022−2022)
11.4 MARKET SHARE ANALYSIS
・ FIGURE 39 MARKET SHARE ANALYSIS (2022) 191
11.5 BRAND/PRODUCT COMPARATIVE ANALYSIS
・ FIGURE 40 INTRAOCULAR LENSES: TOP TRENDING BRANDS/PRODUCTS
11.5.1 BRAND/PRODUCT COMPARATIVE ANALYSIS
・ FIGURE 41 COMPARATIVE ANALYSIS OF KEY BRANDS OF INTRAOCULAR LENS MARKET
11.6 COMPANY EVALUATION MATRIX
11.6.1 STARS
11.6.2 EMERGING LEADERS
11.6.3 PERVASIVE PLAYERS
11.6.4 PARTICIPANTS
・ FIGURE 42 COMPANY EVALUATION MATRIX (2022)
11.6.5 COMPANY FOOTPRINT
・ TABLE 199 INTRAOCULAR LENS MARKET: TYPE FOOTPRINT ANALYSIS
・ TABLE 200 INTRAOCULAR LENS MARKET: MATERIAL FOOTPRINT ANALYSIS
・ TABLE 201 INTRAOCULAR LENS MARKET: APPLICATION FOOTPRINT ANALYSIS
・ TABLE 202 INTRAOCULAR LENS MARKET: END-USER FOOTPRINT ANALYSIS
・ TABLE 203 INTRAOCULAR LENS MARKET: REGIONAL FOOTPRINT
11.7 STARTUP/SME EVALUATION MATRIX
11.7.1 PROGRESSIVE COMPANIES
11.7.2 DYNAMIC COMPANIES
11.7.3 RESPONSIVE COMPANIES
11.7.4 STARTING BLOCKS
・ FIGURE 43 STARTUP/SME EVALUATION MATRIX (2022)
11.7.5 COMPETITIVE BENCHMARKING
・ TABLE 204 DETAILED LIST OF KEY STARTUPS/SMES
11.8 COMPETITIVE SCENARIOS AND TRENDS
・ TABLE 205 INTRAOCULAR LENS MARKET: KEY DEALS (2020−2023)
・ TABLE 206 INTRAOCULAR LENS MARKET: KEY PRODUCT LAUNCHES (2020−2023)
・ TABLE 207 INTRAOCULAR LENS MARKET: OTHER KEY DEVELOPMENTS (2020−2023)
12 COMPANY PROFILES
12.1 KEY PLAYERS 205
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
12.1.1 ALCON, INC.
・ TABLE 208 ALCON INC.: BUSINESS OVERVIEW
・ FIGURE 44 ALCON, INC.: COMPANY SNAPSHOT (2022)
12.1.2 JOHNSON & JOHNSON VISION CARE, INC.
・ TABLE 209 JOHNSON & JOHNSON VISION CARE, INC.: BUSINESS OVERVIEW
・ FIGURE 45 JOHNSON & JOHNSON VISION CARE, INC.: COMPANY SNAPSHOT (2022)
12.1.3 BAUSCH + LOMB
・ TABLE 210 BAUSCH + LOMB: BUSINESS OVERVIEW
・ FIGURE 46 BAUSCH & LOMB: COMPANY SNAPSHOT (2022)
12.1.4 CARL ZEISS MEDITEC AG
・ TABLE 211 CARL ZEISS MEDITEC AG: BUSINESS OVERVIEW
・ FIGURE 47 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2022)
12.1.5 HOYA SURGICAL OPTICS
・ TABLE 212 HOYA SURGICAL OPTICS: BUSINESS OVERVIEW
・ FIGURE 48 HOYA SURGICAL OPTICS: COMPANY SNAPSHOT (2022)
12.1.6 STAAR SURGICAL COMPANY
・ TABLE 213 STAAR SURGICAL COMPANY: BUSINESS OVERVIEW 222
・ FIGURE 49 STAAR SURGICAL COMPANY: COMPANY SNAPSHOT (2022)
12.1.7 SANTEN PHARMACEUTICAL CO., LTD.
・ TABLE 214 SANTEN PHARMACEUTICAL CO., LTD.: BUSINESS OVERVIEW
・ FIGURE 50 SANTEN PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT (2022)
12.1.8 NIDEK CO., LTD.
・ TABLE 215 NIDEK CO., LTD.: BUSINESS OVERVIEW
12.1.9 LENSTEC, INC.
・ TABLE 216 LENSTEC, INC.: BUSINESS OVERVIEW
12.1.10 RAYNER GROUP
・ TABLE 217 RAYNER GROUP: BUSINESS OVERVIEW
12.1.11 BVI
・ TABLE 218 BVI: BUSINESS OVERVIEW
12.1.12 OPHTEC B.V.
・ TABLE 219 OPHTEC B.V.: BUSINESS OVERVIEW 231
12.1.13 SAV-IOL SA
・ TABLE 220 SAV-IOL SA: BUSINESS OVERVIEW
12.1.14 APPASAMY ASSOCIATES PRIVATE LIMITED
・ TABLE 221 APPASAMY ASSOCIATES PRIVATE LIMITED: BUSINESS OVERVIEW
12.1.15 ATIA VISION, INC.
・ TABLE 222 ATIA VISION, INC.: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 BIOTECH
12.2.2 TELEON SURGICAL BV
12.2.3 OMNI LENS PVT. LTD.
12.2.4 EYEKON MEDICAL
12.2.5 HUMANOPTICS HOLDING AG
12.2.6 CARE GROUP
12.2.7 SIFI S.P.A.
12.2.8 HANITA LENSES LTD.
12.2.9 EXCELLENT HI-CARE PVT LTD. 240
12.2.10 ADVIN HEALTH CARE
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS